How do you pick the right drug assets?—with Mika Newton

Picking the right drugs is a high-stakes game. Get it right more often than the competition, and the rewards are massive. Miss a few, and you’re out. So how do top investors and biotech leaders make smart bets? Understanding what pharma actually wants, securing multiple key advocates, and strategically managing risk are all part of the playbook. From clinical-stage assets to investor-backed decision-making, this deep dive unpacks how biotech companies position themselves for success—and what separates the winners from the rest.